| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 31 Jan 2025 | 13 Jan 2025 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Friday 31st January 2025 at 03.30 P.M. at the registered office of the Company at A-101 Pratik Industrial Estate Next to Fortis Hospital Mulund Link Road Mumbai Maharashtra -400078 inter-alia to consider approve and take on record the Un-Audited Financial Results of the Company for the quarter ended 31st December 2024. We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st January, 2025 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2024 As required under Regulation 30 of SEBI, we are pleased to submit our Financial Unaudited Results for the Quarter and None Months Ended on 31-12-2024. Kindly take the same on records. (As per BSE Announcement Dated on 31/01/2025) | ||
| Board Meeting | 30 Oct 2024 | 14 Oct 2024 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Wednesday 30th October 2024 at 03.30 P.M. at the registered office of the Company at A-101 Pratik Industrial Estate Mulund-Link Road Mumbai Maharashtra 400078 inter-alia to consider approve and take on record the Un-audited Financial Results of the Company for the quarter and half year ended 30th September2024 We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 30th October, 2024 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and half year ended on 30th September, 2024. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 30th October, 2024 received from Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and half year ended on 30th September, 2024 We would like to inform you that the Board of Director in their meeting held on 30-10-2024 inter alia considered and approve the Unaudited Financial Results for the Quarter Ended 30-9-2024. Kindly take the same on records (As per BSE Announcement Dated on 30/10/2024) | ||
| Board Meeting | 8 Aug 2024 | 1 Aug 2024 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation2g(2)& 33 of SEBI (LODR) Regulations2015 is scheduled to be held on Thursday 8th Aug 2024 at 03.30 P.M at the registered office of the Company at A-101 Pratik Industrial Estate Mulund-Link Road Mumbai Maharashtra400078 inter-alia to consider approve and take on record the following agenda; 1. To Consider and approve the Directors Report for the year ended 3Lst March 2024. 2. To Consider and approve the Management Discussion Report Corporate Governance Report CEOs certification & other documents for the year ended 31st March2024. 3. To Consider and approve the Secretarial Audit Report without any disqualification) issued by M/s. Sanjay Dholakia &Associates Practising Company Secretaries for the year ended 31st March2024. The Meeting of Board of Directors was held on Thursday, 8th August, 2024 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board approved Directors Report for the year ended 31st March, 2024. 2. The Board also approved Management Discussion Report, Corporate Governance Report, CEOs certification & other documents for the year ended 31st March, 2024 (As Per BSE Announcement dated on 08.08.2024) | ||
| Board Meeting | 31 Jul 2024 | 17 Jul 2024 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2024 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Wednesday 31st July 2024 at 03.30 P.M. at the registered office of the Company at A-101 Pratik Industrial Estate Mulund-Link Road Mumbai Maharashtra 400078 inter-alia to consider approve and take on record the Un-Audited Financial Results of the Company for the quarter ended 30th June 2024. The Meeting of Board of Directors was held on Monday, 31st July, 2024 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2024 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, the Statutory Auditors (Independent Auditors) have carried out Limited Review of the above results. Please find enclosed copy of unaudited financial results along with Limited Review Report for the quarter ended 30th June, 2024. 2. The Board approved Directors Report for the year ended 31st March, 2024. 3. The Board also approved Management Discussion Report, Corporate Governance Report, CEOs certification & other documents for the year ended 31st March, 2024. The Board Meeting commenced at 3:30 p.m. and concluded at 5.30 p.m. (As per BSE Announcement Dated on 31/07/2024) | ||
| Board Meeting | 29 May 2024 | 4 May 2024 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Notice pf Board Meeting Pursuant Regulation 29(2) SEBI (LODR) Regulation 2015. The Board Meeting is scheduled on 29th May2024 for the Approval of Financial Results for the Quarter and Year ended on 31-03-2024 at the registered office of the company at 3.30 pm . Kindly take the same on records . In accordance with Regulation 33 of the Listing Regulations: 1) The Board has discussed and approved Annual Audited Standalone Financial Results of the Company prepared as per Indian Accounting Standard (IND-AS) along with Auditors Report thereon and Statement of Assets and Liabilities, for the quarter and financial year ended 31st March 2024. 2) M/s. Vora & Associates, Chartered Accountants having Firm Regn. No. 111612W, Statutory Auditors have issued an Audit report with unmodified opinion(s) with respect to Audited Standalone Financial Results for the year ended March 31, 2024. 3) Declaration duly certified by the Chief Financial Officer of the Company to the effect that Auditors have submitted their Report with unmodified opinion. The Board Meeting commenced at 03:30 p.m. and concluded at 5:30 p.m. Read less.. (As Per BSE Announcement Dated on 29.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
